TRI$89.43

Thomson Reuters (TRI) exhibits consistent, albeit moderating, revenue growth, ranging from 2.52% to 6.83% annually. Gross margins have shown impressive expansion, moving from 31.16% to 38.76%, while operating margins also improved significantly before a slight dip in the latest two years. The translation of top-line growth to bottom-line has been volatile, largely due to substantial fluctuations in 'Total Non-Operating Income (Expense)' and 'Provision for Income Taxes'. For example, 2021 saw an unusually high non-operating income, significantly boosting pretax and net income. Assuming TRI operates in the professional information services sector, its expanding gross and operating margins, combined with strong EBITDA margins (40-45% in recent years), suggest a high-quality business model. However, the inconsistency in net income driven by non-operating items and tax provisions presents a key risk, obscuring the underlying earnings durability. This volatility warrants close scrutiny, despite healthy core operational performance.

Thomson Reuters Corporation's balance sheet indicates a generally healthy but evolving financial position. Current assets have shown growth from $2,453M in FY21 to $3,490M in FY24 before a significant dip to $2,228M in FY25, largely driven by a sharp decline in cash. This impacts liquidity, though total current liabilities remain manageable. Long-term debt has steadily decreased from $3,786M to $1,328M, significantly improving solvency and leverage. Total assets have declined, primarily due to the reduction in long-term investments, while goodwill and other intangible assets have risen, suggesting acquisition activity or revaluation. Shareholders' equity has been relatively stable, with some fluctuation, indicating a consistent underlying capital base. The notable decrease in cash in FY25 is a key area to monitor for future liquidity.

Thomson Reuters exhibits strong and consistently growing operating cash flow, increasing from $1,773 million in FY21 to $2,651 million in FY25, demonstrating robust core business performance. Free cash flow (FCF) also shows a healthy upward trend, rising from $1,286 million to $2,017 million over the same period, with FCF margins consistently above 20%. The company has managed its capital expenditures responsibly, maintaining them within a reasonable range relative to its operating cash flow. In terms of capital allocation, Thomson Reuters has consistently returned value to shareholders through share repurchases and increasing common dividends, without over-relying on debt. While there was a significant increase in investing cash flow in FY23 due to proceeds from asset sales, the underlying operational cash generation remains strong and sustainable.

Thomson Reuters exhibits mixed liquidity, with current and quick ratios generally below 1.0 but showing a slight improvement from FY22 to FY24 before a recent dip. Leverage is well-managed, with debt-to-equity consistently below 0.4 and debt-to-EBITDA declining significantly over the period, indicating a decreasing reliance on debt relative to earnings. Asset turnover shows a gradual improvement, suggesting increasing efficiency in utilizing assets to generate sales. Profitability and returns are healthy, with ROE, ROA, and ROIC showing strong improvement from FY21 to FY24, although some metrics have softened slightly in the most recent period. Overall, the company demonstrates solid financial health with strong capital efficiency and manageable debt levels, despite some variability in short-term liquidity.

Thomson Reuters Corporation (TRI) shows a mixed but generally improving growth trajectory. Historical revenue growth peaked in FY 2021 at 6.08% before slowing, recovering to 6.83% in FY 2024, and is projected to reach 8.87% by FY 2026. EPS growth has been volatile, with significant swings including a 412.25% surge in FY 2021 and a -76.09% drop in FY 2022, followed by a -15.74% dip in FY 2024 before an estimated rebound to 33.83% in FY 2026. The forward P/E of 20.05 for FY 2026, dropping to 17.46 for FY 2027, appears reasonable considering the projected mid-to-high single-digit revenue growth and double-digit EPS recovery. Analyst sentiment is positive, with a 'Buy' consensus rating from 11 analysts and a median price target of $156. The recommendation trend from October '25 to March '26 shows stable Strong Buy/Buy ratings, indicating sustained confidence.